Mechanisms of Action and Clinical Uses of Estramustine

This publication has 18 references indexed in Scilit:

• Interaction of Estramustine with Microtubule Associated Proteins in Vitro
  Annals of the New York Academy of Sciences, 1987
• Nuclear protein matrix as a target for estramustine‐induced cell death
  The Prostate, 1986
• Interaction of estramustine phosphate with microtubule‐associated proteins
  FEBS Letters, 1985
• Estramustine‐induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC‐3
  The Prostate, 1984
• Comparison of Estramustine Phosphate, Methotrexate and cis-Platinum: in Patients with Advanced1 Hormone Refractory Prostate Cancer
  Journal of Urology, 1983
• Growth and Cell Survival Following Treatment with Estramustine, Nor-Nitrogen Mustard, Estradiol and Testosterone of a Human Prostatic Cancer Cell Line (DU 145)
  Journal of Urology, 1982
• Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®).
  Scandinavian Journal of Urology and Nephrology, 1981
• A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II
  Cancer, 1979
• Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.
  Proceedings of the National Academy of Sciences, 1979
• Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to Oestrogen
  Acta Pharmacologica et Toxicologica, 1979